Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Not applicable Interventional

RejuvenAir® System Trial for COPD With Chronic Bronchitis

ClinicalTrials.gov ID: NCT03893370

Public ClinicalTrials.gov record NCT03893370. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 4, 2026, 9:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Sham Controlled Prospective Randomized Clinical Trial of the RejuvenAir® System for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease With Chronic Bronchitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Chronic Obstructive Pulmonary Disease (COPD) is defined as an impaired ability to move air within the lungs and is a major public health problem that is projected to rank fifth worldwide in terms of disease burden and third in terms of mortality. Chronic bronchitis (CB) is a common clinical phenotype within the umbrella of a COPD diagnosis and is classically defined as chronic cough and sputum production for 3 months a year for 2 consecutive years2, but many studies have used different definitions to define it- chronic cough and sputum production for one year or cough and sputum production on most days of the week. CB is associated with multiple clinical consequences, including; the worsening of lung function decline, increasing risk of acute exacerbations of COPD, increased risk of developing pneumonia, reduced health related quality of life, and an increase in all-cause mortality.

Study identification

NCT ID
NCT03893370
Recruitment status
Not listed
Study type
Interventional
Phase
Not applicable
Lead sponsor
CSA Medical, Inc.
Industry
Enrollment
210 participants

Conditions and interventions

Interventions

Device

Eligibility (public fields only)

Age range
40 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 9, 2020 (Actual)
Primary completion
May 2025 (Estimated)
Completion
Sep 2026 (Estimated)
Last update posted
Jun 3, 2024

2020 – 2026

United States locations

U.S. sites
26
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
Honor Health Scottsdale Arizona 08258 —
El Camino Hospital Mountain View California 94040 —
University of California, Davis Medical Center Sacramento California 95817 —
Advanced Pulmonary Research Institute Loxahatchee Groves Florida 33470 —
Sarasota Memorial Hospital Sarasota Florida 34239 —
Northwestern University Chicago Illinois 60611 —
Louisiana State University Medical Center Shreveport Louisiana 71103 —
University of Maryland Baltimore Maryland 21201 —
Johns Hopkins Universtiy Baltimore Maryland 21287 —
Beth Israel Deaconess Medical Center Boston Massachusetts 02215 —
Henry Ford Health System Detroit Michigan 48202 —
Spectrum Health Grand Rapids Michigan 49503 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
Cooper Health System Camden New Jersey 08103 —
Duke University Durham North Carolina 27705 —
University Of Cincinnati Cincinnati Ohio 45267 —
The Cleveland Clinic Foundation Cleveland Ohio 44195 —
The Ohio State Universisty Columbus Ohio 43210 —
Clinical Research Associates of Central PA Altoona Pennsylvania 16601 —
Temple University - Of the Commonwealth System of Higher Education Philadelphia Pennsylvania 19140 —
Medical University of South Carolina Charleston South Carolina 29425 —
Prisma Health - Midlands Columbia South Carolina 29203 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
St. David's Georgetown Hospital Georgetown Texas 78626 —
University of Wisconsin Hospital and Clinics Madison Wisconsin 53792 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03893370, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 3, 2024 · Synced Oct 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03893370 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →